Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

James Abbey Ph.D.

James Abbey, Ph.D.

James Abbey, Ph.D.

James Abbey, Ph.D.

Affiliate Assistant Member 
Department of Nanomedicine
The Methodist Hospital Research Institute

International Strategic Collaboration Adviser
Strategic Director, Texas/UK Collaborative
Collaborations Manager, Institute of Life Science and Centre for NanoHealth
Company Secretary, Calon Cardio-Technology Limited
Swansea University

E-mail:  j.v.abbey@swansea.ac.uk
Phone: 011-44-1792-602313


Ph.D.   University of Wales, Swansea, Wales, UK (Nanotechnology)
MBA   University of Wales, Swansea, Wales, UK
B.S.   University of North Texas, Denton, Texas, USA (Human Resource Management)


Dr. James Abbey is the international collaborations adviser and director of the Texas/UK Collaborative & International Collaboration at Swansea University in Wales, United Kingdom. In his role at Swansea University, Dr. Abbey helped establish the Center for NanoHealth at Swansea University.  He is also one of the driving forces behind the Texas/UK Collaborative & International Collaboration, which involves a consortium of partnering institutions across the United Kingdom and Texas. 

The Texas-United Kingdom Collaborative harnesses the collective experience and ambition of 10 universities and medical colleges in Texas and eight of the UK's top universities.  Dr. Abbey also spearheaded the establishment of a joint Ph.D. training program between the Methodist Academy and Swansea University.  This formal affiliation agreement will bring Ph.D. students to The Methodist Hospital Research Institute for translational research training.  As an Affiliate Assistant Member of the Research Institute, Dr. Abbey facilitates the collaboration of investigators at Swansea University and Methodist, and is also responsible for the oversight of the joint predoctoral  training program.

Description of Research

Dr. Abbey’s research interest are in collaborative medical discoveries and translation in the areas of biologics, nanotechnology, and chemistry; involvement in the research of open innovation systems and the affect of collaboration on the development of novel therapeutics; and design of a best-in-class, flexible, biopharmaceutical research, development, training, and production facility focused on hybrid and disposable technologies and equipment for rapid development and production of biopharmaceutical products.

Dr. Abbey’s research goal is to provide rapid, cost-effective, FDA-EMEA-MHRA-compliant, and scalable manufacturing facilities to enable an array of new products to enter both in vitro and in vivo clinical trials.

Major Areas of Research

Nanotechnology, biologics, chemistry, therapeutics, preclinical studies

Recent Publications

Ferrati S, Shamsudeen S, Summers HD, Rees P, Abbey JV, Schmulen J, Liu X, Wong ST, Bean AJ, Ferrari M, Serda RE. Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small. 2012 Oct 22;8(20):3151-60. PMID: 22930522

Abbey JV, Davies GH, Mainwaring L. Vorsprung durch Technium: Towards a system of Innovation in South-west Wales. Regional Studies, Vol. 42.2, pp. 281 – 293, March 2008. DOI:10.1080/00343400601147281